Asklepion - Liquid Formulation Of Ursodeoxycholic Acid - Ownership and Business Overview

Life ScienceCompany

Asklepion - Liquid Formulation Of Ursodeoxycholic Acid Ownership

Who owns Asklepion - Liquid Formulation Of Ursodeoxycholic Acid?

Asklepion - Liquid Formulation Of Ursodeoxycholic Acid is owned by Travere Therapeutics. It was acquired on June 20, 2016.

Asklepion - Liquid Formulation Of Ursodeoxycholic Acid Business Overview

Where is Asklepion - Liquid Formulation Of Ursodeoxycholic Acid headquartered?

Asklepion - Liquid Formulation Of Ursodeoxycholic Acid is headquartered in United States.

What sector is Asklepion - Liquid Formulation Of Ursodeoxycholic Acid in?

Asklepion - Liquid Formulation Of Ursodeoxycholic Acid is a life science company.

Life Science M&A Summary in 2016

Out of 60 sectors in the Mergr database, life science ranked 8 in number of deals in 2016. The largest life science acquisition in 2016 was Baxalta - which was acquired by Shire for $32.0B.

Join Mergr to view all 292 acquisitions of life science companies in 2016, including 31 acquisitions by private equity firms, and 261 by strategics.

Asklepion - Liquid Formulation Of Ursodeoxycholic Acid


United States,

Asklepion - Liquid Formulation Of Ursodeoxycholic Acid also known as ursodiol or UDCA, ursodeoxycholic acid is a naturally occurring hydrophilic bile acid derived from cholesterol, which is indicated for the treatment of PBC and currently prescribed only in solid forms. Introducing a liquid formulation of ursodeoxycholic acid would provide healthcare professionals with a dosing alternative for patients who have difficulty swallowing tablets or capsules, and may facilitate increased compliance.


Company Summary

SECTOR

Life Science

 Subscribe to unlock this and 202,409
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 194K M&A Transactions
  • 198K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Asklepion - Liquid Formulation Of Ursodeoxycholic Acid

Life Science Companies , United States Companies

Related Lists for Life Science Companies

Largest Life Science Companies , Acquisitive Life Science Companies , Recently Acquired Life Science Companies , Recently Sold Life Science Companies , Private Life Science Companies , Public Life Science Companies , Acquired Life Science Companies , PE Backed Life Science Companies

Related Lists for United States Companies

Largest United States Companies , Acquisitive United States Companies , Recently Acquired United States Companies , Recently Sold United States Companies , Private United States Companies , Public United States Companies , Acquired United States Companies , PE Backed United States Companies
Mergr

Product

Company

Legal